C09972569 / invoice 10000
Species:CANINE
Breed:Maltese Cross
Age (years):14
Diagnosis or signs:see notes
Consult notes
02/03/2026 Diagnosis: Pulmonary carcinoma, post CT surgical resection at VRH, History: Gizzie has been very well. Her appetite, thirst, toileting and energy levels remain normal. There are no new concerns with Gizzie. Physical Examination findings: Bright, alert and responsive. Mm pink, crt < 2 secs, HR 140, RR panting, Temp 38.9, Wt: 5.56 Cardiovascular: no notable murmurs or arrythmias auscultated, femoral pulses good and synchronous Respiratory: normal respiratory rate and effort, normal bronchovesicular sounds on auscultation, no visible nasal discharge Gastrointestinal: soft comfortable abdomen on palpation, no strong repeatable focus of pain, Rectal exam: Musculoskeletal: no strong repeatable focus of pain on gentle manipulation of limbs and joints, no notable lameness on walk Neurological: cranial nerves intact, no notable ataxia Integument: no obvious lesions Otic/Ocular: normal ocular and otic structures Lymph Nodes: no peripheral lymphadenopathy noted Laboratory results: Full bloods performed last Thursday Treatment: 4.12mg vinorelbine (13mg/m2) was administered IV via a 22g catheter in the x vein using the closed injection Equashield system. Comments: We will see Gizzie again in 1 week time for vinorelbine. Please feel free to call or email if you have any further queries regarding Gizzie.
Previous claim history (5)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-02-10 | C09885994 | CARCINOMA/CARCINOMA IN SITU - LUNG (PULMONARY) PARENCHYMA |
| 2026-01-27 | C09818574 | CARCINOMA/CARCINOMA IN SITU - LUNG (PULMONARY) PARENCHYMA |
| 2026-01-22 | C09793818 | HEPATOPATHY (LIVER DISORDER) |
| 2026-01-15 | C09764386 | HEPATOPATHY (LIVER DISORDER) |
| 2025-12-23 | C09670652 | SPLENIC NODULES |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_consultation-revisit | 205.00 | 2026-03-02 | — |
| 20000 | tstarc_chemotherapy | 285.00 | 2026-03-02 | — |
| 30000 | tstarc_chemotherapy | 220.00 | 2026-03-02 | — |
| 40000 | tstarc_anti-nausea_medication | 97.40 | 2026-03-02 | — |
| 50000 | tstarc_trazodone | 50.55 | 2026-03-02 | — |
UPM+
- DG00334CARCINOMA/CARCINOMA IN SITU - LUNG (PULMONARY) PARENCHYMADSTP_carcinoma
Variant (sleepy_king)
CARCINOMA/CARCINOMA IN SITU
DSTP_carcinoma
Conf: 0.980
Threshold: 0.33
Above: ✓
Correct?